256 results on '"Gilbert, Alexandra"'
Search Results
2. Collaborating with cancer patients and informal caregivers in a European study on quality of life: protocol to embed patient and public involvement within the EUonQoL project
3. Advancing patient-centric care: integrating patient reported outcomes for tolerability assessment in early phase clinical trials – insights from an expert virtual roundtable
4. Silent casualties of Christchurch's earthquakes
5. Protecting your records from accidental loss
6. Setting International Standards in Analyzing Patient-Reported Outcomes and Quality of Life Endpoints in Cancer Clinical Trials-Innovative Medicines Initiative (SISAQOL-IMI): stakeholder views, objectives, and procedures
7. List of contributors
8. Patient perspectives
9. Report forms
10. Combined PET-CT and MRI for response evaluation in patients with squamous cell anal carcinoma treated with curative-intent chemoradiotherapy
11. Prognostic factors for patients with anal cancer treated with conformal radiotherapy—a systematic review
12. Development and validation of prognostic models for anal cancer outcomes using distributed learning: protocol for the international multi-centre atomCAT2 study
13. International consensus recommendations on key outcome measures for organ preservation after (chemo)radiotherapy in patients with rectal cancer
14. XX. Les activités de plein air accessibles aux personnes ayant des incapacités
15. The use of master protocols for efficient trial design to evaluate radiotherapy interventions: a systematic review
16. Patient position verification in magnetic-resonance imaging only radiotherapy of anal and rectal cancers
17. Contributors
18. Molecular linkages among Aβ, tau, impaired mitophagy, and mitochondrial dysfunction in Alzheimer’s disease
19. Radical surgery versus organ preservation via short-course radiotherapy followed by transanal endoscopic microsurgery for early-stage rectal cancer (TREC): a randomised, open-label feasibility study
20. Optimising individual treatment regimes and patient outcomes through the use of patient-reported toxicity assessments in patients treated with pelvic radiotherapy
21. CONCORDE: A phase I platform study of novel agents in combination with conventional radiotherapy in non-small-cell lung cancer
22. Cohort study investigating evolution and factors associated with dyspnoea after anatomic lung resection
23. Functional Outcomes and Health-Related Quality of Life After Curative Treatment for Rectal Cancer: A Population-Level Study in England
24. Agreement between youth and caregiver report of pain and functioning in pediatric sickle cell disease: PedsQL sickle cell disease module.
25. Agreement between youth and caregiver report of pain and functioning in pediatric sickle cell disease: PedsQL sickle cell disease module
26. Lived Experiences and Technology in the Design of Urban Nature Parks for Accessibility
27. Phase I–III development of the EORTC QLQ-ANL27, a health-related quality of life questionnaire for anal cancer
28. 1294: A Multi-Omics Database Using Clinical Trial Data for Rectal Cancer Radiotherapy Outcome Prediction
29. 1232: Modern era radical radiotherapy toxicity: a preliminary CONCORDE analysis of the calibration arm
30. Setting International Standards in Analyzing Patient-Reported Outcomes and Quality of Life Endpoints in Cancer Clinical Trials-Innovative Medicines Initiative (SISAQOL-IMI): stakeholder views, objectives, and procedures
31. Acute and Late Adverse Events Associated With Radical Radiation Therapy Prostate Cancer Treatment: A Systematic Review of Clinician and Patient Toxicity Reporting in Randomized Controlled Trials
32. Deep learning with visual explanation for radiotherapy-induced toxicity prediction
33. International Validation of the EORTC QLQ-ANL27, a Field Study to Test the Anal Cancer-Specific Health-Related Quality-of-Life Questionnaire
34. Online Symptom Monitoring During Pelvic Radiation Therapy: Randomized Pilot Trial of the eRAPID Intervention
35. Toxicity Prediction in Pelvic Radiotherapy Using Multiple Instance Learning and Cascaded Attention Layers
36. Systematic Review of Radiation Therapy Toxicity Reporting in Randomized Controlled Trials of Rectal Cancer: A Comparison of Patient-Reported Outcomes and Clinician Toxicity Reporting
37. Use of patient-reported outcomes to measure symptoms and health related quality of life in the clinic
38. Quality-of-life outcomes in older patients with early-stage rectal cancer receiving organ-preserving treatment with hypofractionated short-course radiotherapy followed by transanal endoscopic microsurgery (TREC): non-randomised registry of patients unsuitable for total mesorectal excision
39. Lived Experiences and Technology in the Design of Urban Nature Parks for Accessibility
40. eRAPID electronic patient self-Reporting of Adverse-events: Patient Information and aDvice: a pilot study protocol in pelvic radiotherapy
41. atomCAT2 - A multicentre study of overall survival, locoregional control and distant metastasis in anal cancer utilising distributed learning
42. Systematic review of the quality of life issues associated with anal cancer and its treatment with radiochemotherapy
43. Linking the European Organisation for Research and Treatment of Cancer Item Library to the Common Terminology Criteria for Adverse Events
44. Listening to the Patient Voice Adds Value to Cancer Clinical Trials
45. A biomarker enrichment trial of anti-EGFR agents in right primary tumor location (rPTL), RAS wild-type (RAS-wt) advanced colorectal cancer (aCRC): ARIEL (ISRCTN11061442).
46. Development and validation of prognostic models for anal cancer outcomes using distributed learning: protocol for the international multi-centre atomCAT2 study
47. Linking the European Organisation for Research and Treatment of Cancer Item Library to the Common Terminology Criteria for Adverse Events
48. The teacher and the cop: the role of 'private space' in increasingly transparent clinical practice
49. A Phase II trial of Higher RadiOtherapy Dose In The Eradication of early rectal cancer (APHRODITE): protocol for a multicentre, open-label randomised controlled trial
50. CONCORDE: a phase Ib platform study of novel agents in combination with conventional radiotherapy in non-small cell lung cancer (NSCLC)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.